黄体期刺激在常规刺激同一卵巢周期中或可改善博洛尼亚标准低反应患者的管理:病例系列
该观察性研究纳入100例符合博洛尼亚标准的低反应患者行DuoStim(同一卵巢周期内卵泡期刺激联合黄体期刺激),黄体期刺激获卵数更多且发育与染色体 competence 与配对卵泡期刺激来源者相似,每意向治疗累积活产率从卵泡期刺激后7%升至DuoStim后15%,而选择常规控制性卵巢刺激的197例患者每意向治疗累积活产率为8%。
要点
- 黄体期刺激获卵数较卵泡期刺激更多,且发育与染色体 competence 相似。
- 每意向治疗累积活产率卵泡期刺激后7%,DuoStim后15%。
- 选择常规控制性卵巢刺激者每意向治疗累积活产率8%,未孕者二次刺激脱失率81%。
核心结论
- 在同一卵巢周期内,黄体期刺激来源卵子提高了符合博洛尼亚标准患者的每意向治疗累积活产率。
- DuoStim策略对管理这一棘手患者群体有前景,尤其可避免首次尝试失败后中断治疗。
研究设计与样本
- 观察性研究(2015-2017年),纳入满足以下至少2项特征的患者:母亲年龄≥40岁和/或既往常规刺激后获卵≤3个和/或卵巢储备降低(窦卵泡计数<7个或抗苗勒管激素<1.1 ng/mL)。
- 无论卵泡期刺激结果如何均启动黄体期刺激;两期均采用相同拮抗剂方案和激动剂触发,行卵胞浆内单精子注射(射精精子)、胚胎植入前非整倍体遗传学检测及玻璃化冻融整倍体单囊胚移植。
主要发现
- 100例患者行卵泡期刺激:母亲年龄42.1±1.4岁,既往体外受精周期获卵≤3个者0.7±0.9个,窦卵泡计数3.8±1.2个,抗苗勒管激素0.56±0.3 ng/mL。
- 黄体期刺激后获卵数更多,且与配对的卵泡期刺激来源卵子具有相似的发育和染色体 competence。
- 每意向治疗累积活产率从卵泡期刺激后7%升至DuoStim后15%。
- 选择常规控制性卵巢刺激策略的197例患者每意向治疗累积活产率为8%,仅17例未孕者首次尝试后返回行第二次刺激(脱失率81%)。
临床怎么用
- 对于符合博洛尼亚标准的低反应患者,可考虑在同一卵巢周期内行黄体期刺激以增加获卵并提高每意向治疗累积活产率。
- DuoStim策略可能有助于避免首次尝试失败后中断治疗。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the clinical contribution of luteal-phase stimulation (LPS) to follicular-phase stimulation (FPS) in a single ovarian cycle (DuoStim) for poor responder patients fulfilling the Bologna criteria. DESIGN: Observational study (years 2015-2017) including women satisfying ≥2 of the following characteristics: maternal age ≥40 years and/or ≤3 oocytes retrieved after previous conventional stimulation and/or reduced ovarian reserve (i.e., antral follicle count <7 follicles or antimüllerian hormone <1.1 ng/mL). The LPS was started regardless of the outcome of the FPS. SETTING: Private in vitro fertilization center. PATIENT(S): A total of 100 of 297 patients fulfilling the Bologna criteria chose to undergo DuoStim. INTERVENTION(S): The FPS and LPS with the same antagonist protocol and agonist trigger, intracytoplasmic sperm injection with ejaculated sperm, preimplantation genetic testing for aneuploidies, and vitrified-warmed euploid single blastocyst transfer. MAIN OUTCOME MEASURE(S): The contribution of LPS to the cumulative live birth rate (CLBR) per intention-to-treat (ITT). RESULT(S): Patients (100) underwent FPS (maternal age, 42.1 ± 1.4 y; previous in vitro fertilization cycles with ≤3 collected oocytes, 0.7 ± 0.9; antral follicle count, 3.8 ± 1.2 follicles; and antimüllerian hormone, 0.56 ± 0.3 ng/mL). Ninety-one patients completed DuoStim. All patients were included in the analysis. More oocytes were obtained after LPS with similar developmental and chromosomal competence as paired FPS-derived ones. The CLBR per ITT increased from 7% after FPS to 15% after DuoStim. Conversely, the CLBR per ITT among the 197 patients that chose a conventional controlled ovarian stimulation strategy was 8%, as only 17 patients who were not pregnant returned for a second stimulation after the first attempt (drop-out rate, 81%). CONCLUSION(S): The LPS-derived oocytes increased the CLBR per ITT in a single ovarian cycle in patients fulfilling the Bologna criteria. The DuoStim strategy is promising to manage this thorny population of patients, especially to avoid discontinuation after a first failed attempt.
引用
- Vaiarelli A, Cimadomo D, Conforti A, et al. Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series. Fertil Steril. 2019. PMID: 31837743. doi:10.1016/j.fertnstert.2019.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。